About-Goldmag

Since GoldMag’s formation back in 2010, it has always been our mission and commitment to excel in the development, manufacture and distribution of cutting-edge products in the field of point-of-care tesing. Innovating upon our internationally patented GoldMag? Particle Technology, we introduced “Magnetic Quantitative Immunochromatography” for point-of-care testing and “PCR-GoldMag Lateral Flow Assay” for genotyping. The company has established a production workshop meeting the requirements of diagnostic reagent cleanliness, has acquired ISO9001, ISO13485 quality system certification, CE certification, obtained the production and business license of medical devices in China. More than 20 diagnostic kits and instruments have been approved by the National Medical Products Administration.
Based on PCR-GoldMag Lateral Flow Assay platform, MTHFR C677T genotyping kit was awarded “the most innovation medical device in China”. Collaborating with Quantum Design, we also developed the Magnetic Immunochromatography system based on the lateral flow format for rapid and accurate immunoassay applicable to a variety of clinical samples. These methods have improved efficiency, and also have remarkable clinical potentials. There are 44 inventive patents including 42 Chinese patents and 2 US patents, covering nanomaterial synthesis, biomolecule modification, clinical diagnostic methodology etc,. GoldMag Nanobiotech brings fast, accurate and innovative products to customers. We believe our innovations will enrich your life.

Xi'an Goldmag Nanobiotech Co., Ltd.

Company Certificates